ABSTRACT
The implanted cells of an allogeneic transplant come from a human donor source other than the treated patient. Allogeneic transplants present certain advantages over allogeneic transplants in that:
• The cells can be tested and ensured to be genetically “normal.” • The cells can be tested for the absence of pathogens. • The products can be sold off the shelf and do not require “bespoke” cell
expansion as required with autologous transplants. • The cells can be obtained from validated cell banks and expanded in
culture prior to implantation.
